High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.
Chen YC, Tsai PC, Huang CF, Chen CY, Hung CH, Chen CH, Tai CM, Cheng PN, Kuo HT, Mo LR, Lo CC, Huang YH, Lin HC, Lee PL, Bair MJ, Chang TS, Lin CY, Wang SJ, Hsieh TY, Yang TH, Peng CY, Yang CC, Chong LW, Huang CW, Lin CW, Chu CH, Tsai MC, Kao JH, Liu CJ, Chuang WL, Tseng KC, Yu ML; TACR investigators.
Chen YC, et al.
J Formos Med Assoc. 2025 Feb 6:S0929-6646(25)00042-7. doi: 10.1016/j.jfma.2025.01.026. Online ahead of print.
J Formos Med Assoc. 2025.
PMID: 39919992
Free article.